Phaim Phaim

Pipeline &
Innovation

Pipeline

 
Patent
Status
Preclinical
Phase 1
Phase 2
Phase 3
Diabetes therapy Granted        
CTLA4-Ig Granted        
CTLA4-Ig with an antigen based vaccine Granted        
T1DM Biomarkers kit Granted        
Psoriasis Pending        

Phaim Drug and Innovation Development

All patents secured via world-wide patent applications.

 

Revenue Streams